Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Olfactory transduction | R-HSA-9751605 | map04740 | liothyronine | 5920 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | liothyronine | 5920 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | napelline | 441749 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | napelline | 441749 | drug-path |
| Asthma | R-HSA-444620 | map05310 | napelline | 441749 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | napelline | 441749 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | napelline | 441749 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | napelline | 441749 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | napelline | 441749 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | napelline | 441749 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | napelline | 441749 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | cefotiam | 2391 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | cefotiam | 2391 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | cefotiam | 2391 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | cefotiam | 2391 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | cefotiam | 2391 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | cefotiam | 2391 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | nitrofural | 38853 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | nitrofural | 38853 | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | nitrofural | 38853 | drug-path |